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ABSTRACT 
Antimicrobial drugs either kill microbes (microbicidal) or prevent the growth of microbes (microbistatic). The streptococcus mutans is a 
bacteria that found in the human mouth cavity. This bacterial strain produces plaque and acids that break down tooth enamel and cause dental 
caries. Gram positive cocci, facultatively anaerobic bacteria that forms rod-like chains. the chemical reaction of 2- hydroxyacetophenones with 
aromatic acylchloride occurs to form 1,3-diketones. This rearrangement reaction proceeds via enolate formation followed by acyl transfer. 
Then it cyclises into flavone.13 As the same of above scheme can be worked out as 2- Methoxybenzoyl Chloride is prepared by reaction of 2- 
methoxybenzoic acid  with  Thionyl chloride and DMF. 2-Methoxybenzoyl Chloride then added to mixture of 2- hydroxyacetophenone and 
pyridine, 2-[(2-Methoxybenzoyl)oxy]acetophenone thus obtained is treated with pyridine and KOH which gives1-(2-Hydroxyphenyl)-3-(2- 
methoxyphenyl)-propan1,3-dione. The result of study indicated that C5 [1-(2- hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one]; is only inactive 
against Streptococcus mutans. All 3-hydroxyflavone derivatives exhibited their MIC to be in range of 250-125 µg/ml., 2,3-dihydroflavan-3-ol 
derivatives exhibited their MIC to be in  range of  1000- 500 µg/ml. The chalcone derivatives exhibited their MIC to be at 250 µg/ml. 
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INTRODUCTION: 
Flavonoids are secondary metabolite. These are synthesized 
by  phenylpropanoid pathway.  
Series of enzyme Phenylalanine Ammonia Lyase (PAL), 
cinnamate 4- hydroxylase (C4H) & 4-Coumarate CoA ligase 
(4CL) catalyzes the conversion of phenylalanine to 4-
coumaroyl-CoA, it then reacts with malonyl CoA. The 
flavonoid biosynthetic rout is starts with the condensation 
process of one molecule of 4-coumaroyl- CoA and three 
molecules of malonyl-CoA, and obtain tetrahydrochalcone. 
This reaction procedure is catalyzing by the chalcone 
synthase enzyme(CHS). Chalcone is convert in to a flavanone 
(naringenin) by the help of enzyme chalcone f- isomerase 
(CHI). The central naringenin and the intermediate is 
converted into various side chains and each convert  into 
different groups of flavonoids. Flavanone 3-hydroxylase 
(F3H) catalyzes the stereo- specific 3-beta-hydroxylation of 
(2S)-flavanones  to  dihydro-flavonols (dihydrokampferol). 
Antimicrobial Activity: 
An antimicrobial is a substance that kills or inhibits the 
growth of microbes such as prokaryotic bacteria, viruses and 
fungus. Antimicrobial drugs either kill microbes 
(microbicidal) or prevent the growth of microbes 
(microbistatic). Since the flavonoids are secondary 
metabolites, they posses inherent ability to combat  with 
infections. Thus they show antimicrobial activity. Lin 
reported a method of synthesis of flavone containing Beta 
fluroethyl thiourea and screened for antimycobacterial 
activity. Sherif B. Abdel Ghani, synthesized flavone 
derivatives using a modified Baker– Venkataraman 
rearrangement and evaluated for antimicrobial activity 
against S.aureus, E.coli etc. Literature states that plant 
flavonoids in toothpastes are responsible for antiplaque 
action and works against tooth decay.1 Plaque-related 
diseases are probably the most common bacterial diseases 
occurring in human society. The flavonoid derivatives which 
posses hydroxylated phenolic nucleus where the C6-C3 unit 
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is linked to an aromatic ring, exhibit a broad range of 
antimicrobial activity. The catechins as found in green tea is 
the one of example of it.54 The streptococcus mutans is a 
bacteria that found in the human mouth cavity. This 
bacterial strain produces plaque and acids that break down 
tooth enamel and cause dental caries. A gram positive cocci, 
facultatively anaerobic bacteria that forms rod-like chains. 
EXPERIMENTAL WORK: 
Synthetic Scheme: 
 
The first step in this mechanism is an acid catalyzed aldol 
condensation between benzaldehyde and a Coumarone to an 
ortho-hydroxychalcone. Bromination of the alkene group 
gives a dibromo-adduct which rearranges to the flavonol by 
reaction with potassium hydroxide, which yield flavonol.13,14 
 
The Baker-Venkataraman rearrangement is the chemical 
reaction of 2- hydroxyacetophenones with aromatic 
acylchloride occurs to form 1,3-diketones. This 
rearrangement reaction proceeds via enolate formation 
followed by acyl transfer. Then it cyclises into flavone.13 As 
the same of above scheme can be worked out as 2- 
Methoxybenzoyl Chloride is prepared by reaction of 2- 
methoxybenzoic acid  with  Thionyl chloride and DMF. 2-
Methoxybenzoyl Chloride then added to mixture of 2- 
hydroxyacetophenone and pyridine, 2-[(2-Methoxybenzoyl) 
oxy]acetophenone thus obtained is treated with pyridine 
and KOH which gives1-(2-Hydroxyphenyl)-3-(2- methoxy 
phenyl)-propan1,3-dione.This is then treated with 
conc.H2SO4 and acetic acid which gives flavone. 
Antibacterial Activity 
The synthesize organic compounds were analyse in vitro for 
their antibacterial activity against Streptococcus mutans 
which is pathogenic in human beings. 
Method: the cup plate agar diffusion method using Nutrient 
agar. 
Preparation of Nutrient broth: 
Nutrient broth (3.8 gm) was dissolved in 100 ml distilled 
water and pH was maintained to 7.2. This solution was 
sterilized by autoclaving at 15 psi for 20 min. 
Preparation of Inoculums: 
24 hours prior to these testing inoculations of the above 
bacterial cultures was made in    the Nutrient broth and 
incubated at 370C for 18-24 hrs. 
Preparation of medium: 
2.8 gm Nutrient agar was dissolved into 100 ml distilled 
water It was sterilized by autoclaving at 15 psi for 20 min. 
Preparation of test solution: 
Each test compound (5 mg) was dissolved in 
dimethylformamide (5 ml) to give stock solution of 
concentration 1000 mcg/ml. Then the 0.1 ml of this solution 
was used for testing. 
Method of testing: 
Nutrient agar plates were prepared by pouring 15-20 ml of 
medium into each sterilised petridish and were allowed to 
set at the room temperature. The cell suspension was 
inoculated over the surface of agar medium using sterile 
cotton. The three cups were scooped in each plate using cork 
borer of 6mm diameter. Then the solution of test compounds 
(0.10 ml) was added in cups by using micropipettes and 
these plates are incubated at 370C for 48 hrs. The zone of 
inhibition is measured in mm. 
Determination of Minimum ihibitory concentration 
(MIC) Method: Tube dilution /Broth dilution method 
Tube dilution technique 
One ml of double strength nutrient broth was added to a set 
of presterilized 5 test tubes (numbered from 1-5). To the 
first test tube, 1 ml complex solution (conc. =2000 µg/ml) 
was added. After mixing, a solution (1 ml) from test tube 
no.1, it was transferred to test tube no.2 so as to obtain 
concentration of 1000 µg/ml. The same procedure (serial  
dilution) was followed for the remaining test tubes from no. 
3 to no. 5 to get the concentration of compounds in the 500 
µg/ml , 250 µg/ml and 125 µg/ml.  From the  5th test tube 1 
ml of solution was discarded so as to get the equal volume in 
each test tube. Thus each tube having concentration of 
(2000, 1000, 500, 250, 125 µg/ml). To each test tube 20 µl of 
Streptococcus mutans suspension was added (inoculation). 
All test tubes were incubated at 37˚C for 24 hours and 
observed the turbidity.  This sets of test  tube  were 
compared for determining the MIC. 
Table 1: MIC experimental set up 
Micro-organism Streptococcus 
mutans 
Media Double strength 
nutrient 
Conc. of Compounds 100µg/ml 
Loaded volume of compounds 1 ml 
Loaded Volume of media 1 ml 
Volume of microbial suspension load 20 µl 
Incubation temperature 37°C 
Incubation period 24 Hrs 
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RUSLTS AND DISCUSSION 
Antimicrobial (Antiplaque) Screening 
Antimicrobial activity against Streptococcus mutans has 
shown satisfactory results. 
Zone of Inhibition 
The diameters of ZOI with streptococcus mutans were found 
to be satisfactory in all derivatives. The observation of ZOI 
suggested the antibacterial activity of tested compounds J1, 
J2, J3, J4, J6, V1, V2, V4 V5, R1, R2, R3, R4, R5, R6 against 
Streptococcus mutans. 
Minimum inhibitory concentration 
On observation of positive results of antimicrobial activity, 
the MICs of synthesized compounds were determined by 
tube dilution method. Studies indicated the requirement of 
inhibitory concentration in order “chalcone derivatives > 
2,3-dihydroflavan-3-ol derivatives > 3-hydroxyflavone 
derivatives. The result of study indicated that C5 [1-(2- 
hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one]; is only 
inactive against Streptococcus mutans. All 3-hydroxyflavone 
derivatives exhibited their MIC to be in range of 250-125 
µg/ml., 2,3-dihydroflavan-3-ol derivatives exhibited their 
MIC to be in  range of  1000- 500 µg/ml. The chalcone 
derivatives exhibited their MIC to be at 250 µg/ml. 
Table 2: Zone of inhibition 
Compound code Zone of inhibition 
(Streptococcus mutans 1000µg/ml) 
J1 13mm 
J2 10 mm 
J3 12mm 
J4 9mm 
J5 NA 
J6 15mm 
V1 6mm 
V2 12mm 
V3 7mm 
V4 6mm 
V5 10mm 
V6 NA 
R1 10mm 
R2 12mm 
R3 13mm 
R4 10mm 
R5 11mm 
R6 9mm 
 
 
Table 3: MIC of flavonoid derivatives with Streptococcus mutans 
Compound 
code 
% Transmittance 
1000 µg/ml 500 µg/ml 250 µg/ml 125 µg/ml 
J1 37 34 30 17 
J2 24 26 29 16 
J3 18 27 17 19 
J4 33 35 28 19 
J5 30 31 29 26 
J6 31 39 34 27 
V1 30 37 41 25 
V2 27 33 30 27 
V3 32 34 36 12 
V4 33 36 25 15 
V5 33 35 28 19 
V6 32 33 30 28 
R1 30 39 35 27 
R2 47 24 21 25 
R3 34 15 18 15 
R4 58 43 23 27 
R5 44 48 32 30 
R6 53 16 13 18 
 
 
Figure 1 MIC of 2-hydroxy chalcone derivatives 
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Figure 2 MIC of 3-hydroxy Flavone derivatives 
 
Figure 3 MIC of 2, 3-dihydroxy Flav-3-ol derivatives 
 
The screening results have shown the contribution of 
electron withdrawing group to antimicrobial activity. As 
electron withdrawing ability increases 
CONCLUSION: 
The 2’-hydroxychalcone derivatives, 3-hydroxyflavone 
derivatives and 2,3- dihydroflavan 3-ol derivatives were 
synthesized and were confirmed by physicochemical and 
spectral analysis. The result of study indicated that C5 [1-(2- 
hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one]; is only 
inactive against Streptococcus mutans. All 3-hydroxyflavone 
derivatives exhibited their MIC to be in range of 250-125 
µg/ml., 2,3-dihydroflavan-3-ol derivatives exhibited their 
MIC to be in  range of  1000- 500 µg/ml. The chalcone 
derivatives exhibited their MIC to be at 250 µg/ml. 
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